Overview

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

Status:
Completed
Trial end date:
2019-05-20
Target enrollment:
Participant gender:
Summary
The objective of this study is to obtain additional data on the efficacy and safety of 12-week course of therapy with Anaferon for children for prevention of influenza and other acute respiratory viral infections in children during the peaks of seasonal morbidity.
Phase:
Phase 4
Details
Lead Sponsor:
Materia Medica Holding